Last reviewed: May 16, 2026
Last updated: May 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
Most GLP-1 injections must be refrigerated at 36–46°F (2–8°C) before first use, though storage rules differ once therapy begins. Proper temperature maintenance preserves medication potency and prevents degradation that could reduce therapeutic benefit or trigger adverse reactions.
Understanding storage requirements is a foundational step in GLP-1 therapy—but it's just one part of successful treatment initiation. PlexusDx emphasizes precision preparation: knowing storage protocols alongside your genetic predispositions in peptide pathways helps you and your provider build a more informed, personalized protocol from day one.
Temperature Requirements Before and After First Use
Before opening, most GLP-1 formulations require continuous refrigeration. Once you inject the first dose, storage changes: some brands allow room-temperature storage (up to 86°F/30°C) for up to 28–30 days, while others require continued refrigeration. Check your specific medication's prescribing information immediately upon receipt.
Freezing GLP-1 injections damages the active compound and renders them ineffective. Do not store in freezer compartments, ice packs, or frozen foods. If accidentally frozen, discard the medication. Consistent, moderate cold temperatures preserve the peptide structure that drives the medication's mechanism of action.
Storage Conditions Across Common Formulations
Compounded GLP-1 medications from licensed 503A pharmacies follow USP guidelines for peptide stability. Your pharmacy will provide exact storage instructions based on your specific formulation. Understanding these details before your first injection reduces waste, prevents treatment delays, and ensures consistent potency throughout your therapy cycle.
| Storage Phase |
Temperature Range |
Duration |
Special Handling |
| Before First Use |
36–46°F (2–8°C) |
Until opened |
Keep in original box; avoid light exposure |
| After First Use (typical) |
Room temperature or 36–46°F |
28–30 days |
Check pharmacy label; some require continued refrigeration |
| In Use (pre-filled pen/syringe) |
Room temp if allowed |
Up to 28 days |
Keep cap on; protect from direct sunlight |
| Traveling/Emergency |
Portable cooling case or ice pack |
Up to 48 hours |
Do not freeze; use insulated travel kits |
Travel, Vacation, and Practical Storage Strategies
If traveling, use an insulated medication case with cooling elements designed to maintain 36–46°F. Never pack GLP-1 injections in carry-on bags exposed to aircraft cabin heat or in checked luggage subject to cargo freezing. Plan ahead by requesting a travel letter from your pharmacy confirming the medication and its storage needs.
Long-term stability varies: most GLP-1 products remain potent for 28–30 days after opening at room temperature, but extended exposure to heat or light degrades the peptide. Do not leave injections in hot cars, direct sunlight, or bathrooms with high humidity. If power loss occurs during home refrigeration, transfer to a cooler with ice packs immediately and contact your pharmacy about replacement options.
Why Storage Quality Matters for Treatment Response
Improper storage—especially repeated temperature fluctuations or heat exposure—can reduce medication potency without visible changes. A degraded GLP-1 injection may not deliver the expected appetite suppression, metabolic benefit, or weight-management support. This can lead patients to incorrectly assume the medication isn't working, when the issue was storage-related potency loss.
Starting GLP-1 therapy requires commitment not just to the injection schedule but to proper storage practices. Your healthcare provider depends on consistent medication quality to evaluate your actual response. Before initiating treatment, confirm your home refrigeration capacity, understand your formulation's specific requirements, and discuss any logistical barriers with your provider or pharmacy team.
How PlexusDx Supports a More Personalized Approach
PlexusDx recognizes that GLP-1 therapy success depends on multiple factors beyond the injection itself—including storage reliability and individual metabolic predispositions. Our Precision Peptide Genetic Test reveals variations in genes like GLP1R, GIPR, MC4R, and FTO that may influence how your body responds to peptide-based treatment. These genetic insights can help provide context as you and your provider develop a comprehensive, personalized treatment plan.
Genetic predispositions in peptide pathways do not predict exact medication response, but they can support a more informed conversation about whether GLP-1 therapy aligns with your metabolic profile. Variants in GLP1R or GIPR genes, for example, may influence receptor sensitivity or baseline appetite-regulation patterns. Understanding your genetic landscape alongside proper storage practices demonstrates a precision-wellness approach to treatment initiation.
Before starting any GLP-1 injection, use the Precision Peptide Genetic Test ($99 add-on or $298 standalone) to assess your predispositions in peptide pathways. Combine these insights with proper storage knowledge and open dialogue with your provider. This foundation helps you maximize treatment safety, efficacy, and adherence from the very first injection.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Stopping Ozempic for Weight Loss: Clinical Considerations
GLP-1 Market History & Genetic Predispositions | PlexusDx